Sel-K1

N/A

Report date: 2025/03/20 09:27:24

Base Information

Drug NameSel-K1
Drug Alias Nameanti-PSGL-1 antibodies (Selexys)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionP-selectin glycoprotein ligand-1 inhibitors
TargetsP-selectin glycoprotein ligand-1
Therapy Area/IndicationsInflammationInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesReprixys Pharmaceuticals Corp
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Ag
Inactive CompaniesReprixys Pharmaceuticals Corp
Active IndicationsInflammatory Bowel Diseases
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A